CD8+T cells in esophageal cancer have been proved to be associated with survival rate, response to neoadjuvant chemotherapy, and lymph node metastasis rate (Zheng et al., 2020). The gene discussed is CD8A; the disease is metastatic malignant neoplasm in the lymph nodes.